Dr. Sofley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 E Greenville St
Ste 3850
Anderson, SC 29621Phone+1 864-512-6024Fax+1 864-512-6123
Education & Training
- Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Internal Medicine, 1986 - 1989
- University of North Carolina at Chapel Hill School of MedicineClass of 1986
Certifications & Licensure
- SC State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2012
- Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- Phase III Acute Coronary Syndrome Start of enrollment: 2009 Mar 01
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Start of enrollment: 2010 Jul 01
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 3359 citationsEvolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseMarc S. Sabatine, Robert P. Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D. Wiviott
The New England Journal of Medicine. 2017-03-17 - 5465 citationsAntiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M. Ridker, Brendan M. Everett, Tom Thuren, Jean G. MacFadyen, William Chang
The New England Journal of Medicine. 2017-08-27 - 5380 citationsApixaban versus Warfarin in Patients with Atrial FibrillationChristopher B. Granger, John H. Alexander, Renato D. Lopes, Elaine M. Hylek, Michael G. Hanna
The New England Journal of Medicine. 2011-09-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: